Bank of Baroda's NMC Settlement Slashes Q1 Profit Amidst Growth

Bank of Baroda (BoB) reported a significant 72% decline in its first-quarter net profit, falling to ₹1,207 crore, largely attributed to a $600 million (approximately ₹5,000 crore) settlement related to the NMC Health litigation. The state-owned lender confirmed the settlement was a commercially driven decision aimed at resolving a protracted legal overhang. Despite the substantial impact on immediate profitability, BoB maintained its fiscal year 2027 (FY27) credit growth guidance. This outlook comes even as the bank demonstrated robust loan growth of 17.4% and an increase in Foreign Currency Non-Resident (FCNR) inflows during the period. The settlement amount effectively absorbed a substantial portion of the quarter's earnings, highlighting the financial burden of resolving legacy issues. The bank's decision to settle reflects a strategic move to de-risk its balance sheet from potential further legal costs and uncertainties. While the immediate impact on profit is severe, the bank's sustained credit growth and stable long-term guidance suggest underlying operational strength and confidence in future earnings capacity. The rise in FCNR inflows could also provide a stable funding source for future lending activities, mitigating some of the liquidity pressures from the settlement.